medigraphic.com
ISSN 0035-0052 (Print)

2006, Number 5

<< Back Next >>

Rev Mex Pediatr 2006; 73 (5)

Candida albicans arthritis in an infant with glycogenesis type. A case report

Jiménez JRN, Coria LJJ, Crespo SD, Gómez BD

Language: Spanish
References: 15
Page: 225-229
PDF size: 55.60 Kb.


ABSTRACT

Septic arthritis is more frequently seen in children than adults, its incidence in children has been estimated in 5.5 to 12 cases by 100.000. Candida spp is ethiological implicated in the arthritis but it is infrequent. Election drug for treatment is amphotericin-B, for two to three weeks, followed by fluconazole during six or more months in order to eradicate the infection and to preserve the joint function. We report a case of an infant with glycogenosis type 1 associated to septic arthritis by C. albicans.


REFERENCES

  1. Krogstad P. Osteomyelitis and septic arthritis. In: Feigin RA, Cherry JD, Deminier GJ, Kaplan SL editors. Textbook of Pediatric Infectious Diseases. 5th Philadelphia: Saunders. 2004.

  2. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WG. Candidemia in a tertiary care hospital: Epidemiology, risk factors and predictors of mortality. Clin Infect Dis 1992; 15: 414-21.

  3. Kossoff EH, Buescher SB, Karlowicz G. Candidemia in a neonatal intensive unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17: 504-8.

  4. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin T, Dawson J, Blumberg HM, Patterson JE et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis J 2000; 19: 319-24.

  5. Swason H, Hughes PA, Messer SA, Lepow ML, Pfaller MA. Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant. J Pediatr 1996; 129: 688-94.

  6. Fernández de Miguel S, Salinas SJA, Clemente PJ, Sánchez GJM, Ruiz CJ, Ramos AJT. Artritis por Candida albicans en un lactante. An Pediatr 2003; 58: 395-6.

  7. Chávez PA, Mendoza NC, Morales GA, Papic GZ, Benveniste DS. Infección osteoarticular por Candida albicans 2000; 17(4): 340-3.

  8. Harris MC, Pereira GR, Myers MD, Cardin AJ, Razdan B, Pleasure J, Bell LM. Candidal arthritis in infants previously treated for systemic candidiasis during the newborn period: Report of three cases. Pediatr Emerg Care 2000; 16(4): 249-251.

  9. Murphy O, Gray J, Wagget J, Pedler SJ. Candida arthritis complicating long term total parenteral nutrition. Ped Infect Dis J 1997; 16: 329.

  10. Barson WJ, Marcon MJ. Successful therapy of Candida albicans arthritis with a sequential intravenous amphotericin B and oral fluconazol regimen. Ped Infect Dis J 1996; 15: 1119-11.

  11. Beaudet AL, Anderson DC, Michels VV, Arion WJ, Lange AJ. Neutropenia and impaired neutrophil migrating in type IB glycogen storage disease. J Pediatr 1980; 97: 906-10.

  12. Hacimustafaoglu M, Cil E, Sarisözen B, Zincirci M, Ildirim I. Bilateral septic arthritis of the knee joint in three children caused by unusual infectious agents. Pediatr Int 2001; 43: 697-700.

  13. Anderson DC, Mace ML, Brinkley BR, Martin RR, Smith CW. Recurrent infection in glycogenosis type IB: Abnormal neutrophil motility related to impaired redistribution of adhesion sites. J Infect Dis 1981; 147: 447-59.

  14. Koven NL, Clark MM, Cody CS, Stanley CA, Baker L, Douglas SD. Impaired chemotaxis and neutrophil (Polimorphonuclear leukocyte) function in glycogenosis type IB. Pediatr Res 1986; 20: 438-42.

  15. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38: 161-89.




2020     |     www.medigraphic.com